Cancer Survivor to Take on 90km Charity Cycle Challenge with Sir Chris Hoy

Mark Cribb, a 50-year-old Bournemouth restaurant owner diagnosed with non-Hodgkin's follicular lymphoma last year, is gearing up for a 90km charity cycle challenge led by six-time Olympic gold medallist Sir Chris Hoy. The challenge, known as the Tour de 4, aims to raise awareness and funds for those living with stage 4 cancer. Cribb, who has undergone six rounds of chemotherapy, 12 rounds of radiotherapy, and ongoing immunotherapy, hopes to raise funds for Wessex Cancer Support through his fundraising page, which has already exceeded £1,200.

Key Takeaways:

  • Mark Cribb, a 50-year-old restaurateur, will participate in the Tour de 4 charity cycle challenge on September 7, aiming to raise funds for Wessex Cancer Support.
  • Cribb was diagnosed with non-Hodgkin's follicular lymphoma 12 months ago and has undergone extensive treatment, including chemotherapy, radiotherapy, and immunotherapy.
  • The Tour de 4 is a 90km ride founded by Sir Chris Hoy to raise awareness and funds for those living with stage 4 cancer.
  • Mark Cribb has already raised over £1,200 through his fundraising page, with all proceeds supporting Wessex Cancer Support's vital services.
  • Wessex Cancer Support provides free, local, and personalized emotional and wellbeing support to anyone affected by cancer in the Wessex area.
  • The charity offers professional counseling, complementary therapies, activities, support groups, and courses, as well as online services.
  • Amanda Ovey, Wessex Cancer Support regional fundraiser, expressed admiration for Mark's determination and fundraising efforts, stating that they will directly support the charity's vital services.

Statistics:

  • 90km: The distance of the Tour de 4 charity bike ride.
  • £1,200: The amount raised by Mark Cribb through his fundraising page.
  • 6 rounds of chemotherapy: The number of chemotherapy rounds Cribb has undergone.
  • 12 rounds of radiotherapy: The number of radiotherapy rounds Cribb has undergone.
  • Ongoing immunotherapy: The treatment Cribb is currently receiving.

Sources:

  • "Byline: Deb Gayen"
  • [Original article text cited as source]